Controlled Drug Delivery
Controlled drug delivery refers to the administration of therapeutic agents in a way that provides a specific and controlled release of the drug over an extended period. This approach aims to optimize the drug's therapeutic effects, minimize side effects, and enhance patient compliance. Various technologies and formulations are employed to achieve controlled drug delivery, and these can be tailored to meet the specific requirements of different drugs and medical conditions.
Mechanisms of Controlled Release:
- Diffusion-Controlled Systems: Drug release occurs through diffusion across a membrane or matrix. The rate of diffusion is influenced by factors like the concentration gradient and the permeability of the matrix.
- Chemically-Controlled Systems: Release is triggered by a chemical reaction, such as drug dissolution or polymer degradation. pH-sensitive polymers or hydrogels are common in chemically-controlled systems.
- Osmotic-Controlled Systems: Osmotic pumps use osmotic pressure to release drugs at a controlled rate. As water enters the system, the drug is pushed out through a small opening.
Challenges and Future Directions:
- Biocompatibility: Ensuring that the materials used in drug delivery systems are biocompatible and do not induce adverse reactions in the body.
- Regulatory Approval: Meeting stringent regulatory requirements for safety and efficacy is a critical challenge in the development and approval of controlled drug delivery systems.
- Personalized Medicine: Advancements in controlled drug delivery are moving towards personalized medicine, tailoring drug release profiles to individual patient needs.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico